The influence of trait anxiety on the elevation of arterial pressure induced by L-NAME in rats

Neuroscience Letters

Volumn 583, Issue , 2014, Pages 11-15

  Garcez, Flávia Barreto ^a   Carvalho, Fábio Ursulino Reis ^a   Soares, Ana Paula dos Santos ^a   Goes, Tiago Costa ^a   dos Santos, Márcio Roberto Viana ^a   Teixeira Silva, Flavia ^a  

^a FEDERAL UNIVERSITY OF SERGIPE   (Brazil)

Author keywords

Blood pressure; Free exploratory paradigm; Hypertension; L NAME; Rats; Trait anxiety

Indexed keywords

N(G) NITROARGININE METHYL ESTER;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANXIETY; ARTICLE; BLOOD PRESSURE MEASUREMENT; BLOOD PRESSURE REGULATION; CLINICAL EVALUATION; CONTROLLED STUDY; CORRELATIONAL STUDY; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; ELEVATED BLOOD PRESSURE; EXPERIMENTAL ANXIETY TEST; FREE EXPLORATORY PARADIGM; HYPERTENSION; MALE; NONHUMAN; OUTCOME ASSESSMENT; RAT; SYSTOLIC BLOOD PRESSURE; TRAIT ANXIETY; WISTAR RAT; ANIMAL; BLOOD PRESSURE; DRUG EFFECTS; PATHOPHYSIOLOGY; PSYCHOLOGY; SPECIES DIFFERENCE;

ANIMALS; ANXIETY; BLOOD PRESSURE; HYPERTENSION; MALE; NG-NITROARGININE METHYL ESTER; RATS, WISTAR; SPECIES SPECIFICITY;

EID: 84907457502     PISSN: 03043940     EISSN: 18727972     Source Type: Journal    
DOI: 10.1016/j.neulet.2014.09.011     Document Type: Article

References (43)

1. Ginty A.T., Carroll D., Roseboom T.J., Philips A.C., de Rooij S.R. Depression and anxiety are associated with a diagnosis of hypertension 5 years later in a cohort of late middle-aged men and women. J. Hum. Hypertens. 2013, 27:187-190.
2. Jonas B.S., Lando J.F. Negative affect as a prospective risk factor for hypertension. Psychosom. Med. 2000, 62:188-196.
3. Jonas B.S., Franks P., Ingram D.D. Are symptoms of anxiety and depression risk factors for hypertension? Longitudinal evidence from the National Health and Nutrition Examination Survey I epidemiologic follow-up study. Arch. Fam. Med. 1997, 6:43-49.
4. Roy-Byrne P.P., Davidson K.W., Kessler R.C., Asmundson G.J.G., Goodwin R.D., Kubzansky L., Lydiard R.B., Massie M.J., Katon W., Laden S.K., Stein M.B. Anxiety disorders and comorbid medical illness. Focus 2008, 6:467-485.
5. Faria M.S., Muscará M.N., Moreno Júnior H., Teixeira S.A., Dias H.B., De Oliveira B., Graeff F.G., De Nucci G. Acute inhibition of nitric oxide synthesis induces anxiolysis in the plus maze test. Eur. J. Pharmacol. 1997, 323:37-43.
6. Salim S., Asghar M., Chugh G., Taneja M., Xia Z., Saha K. Oxidative stress: a potential recipe for anxiety, hypertension and insulin resistance. Brain Res. 2010, 1359:178-185.
7. Srinivasan J., Suresh B., Ramanathan M. Differential anxiolytic effect of enalapril and losartan in normotensive and renal hypertensive rats. Physiol. Behav. 2003, 78:585-591.
8. Grimsrud A., Stein D.J., Seedat S., Williams D., Myer L. The association between hypertension and depression and anxiety disorders: results from a nationally-representative sample of South African adults. PLoS ONE 2009, 4:e5552.
9. Goes T.C., Antunes F.D., Teixeira-Silva F. Trait and state anxiety in animal models: is there correlation?. Neurosci. Lett. 2009, 450:266-269.
10. Griebel G., Belzung C., Misslin R., Vogel E. The free-exploratory paradigm: an effective method for measuring neophobic behaviour in mice and testing potential neophobia-reducing drugs. Behav. Pharmacol. 1993, 4:637-644.
11. Hughes R.N. Behaviour of male and female rats with free choice of two environments differing in novelty. Anim. Behav. 1968, 16:92-96.
12. Teixeira-Silva F., Antunes F.D., Silva P.R.S., Goes T.C., Dantas E.C., Santiago M.F., Andrade R.M. The free-exploratory paradigm as a model of trait anxiety in rats: test-retest reliability. Physiol. Behav. 2009, 96:729-734.
13. Ribeiro M.O., Antunes E., De-Nucci G., Lovisolo S.M., Zatz R. Chronic inhibition of nitric oxide synthesis: a new model of arterial hypertension. Hypertension 1992, 20:298-303.
14. Bartunek J., Weinberg E.O., Tajima M., Rohrbach S., Katz S.E., Douglas P.S., Lorell B.H. Chronic N(G)-nitro-l-arginine methyl ester-induced hypertension: novel molecular adaptation to systolic load in absence of hypertrophy. Circulation 2000, 101(February (4)):423-429.
15. Baylis C., Mitruka B., Deng A. Chronic blockade of nitric oxide synthesis in the rat produces systemic hypertension and glomerular damage. J. Clin. Invest. 1992, 90:278-281.
16. Antunes F.D., Goes T.C., Vígaro M.G., Teixeira-Silva F. Automation of the free-exploratory paradigm. J. Neurosci. Methods 2011, 97:216-220.
17. Numaguchi K., Egashira K., Takemoto M., Kadokami T., Shimokawa H., Sueishi K., Takeshita A. Chronic inhibition of nitric oxide synthesis causes coronary microvascular remodeling in rats. Hypertension 1995, 26:957-962.
18. Rowberg A., Franklin D., Van Citters R.L. Nontraumatic method for measurement of blood pressure in animals with tails. J. Appl. Physiol. 1969, 27:301-302.
19. Malkoff J. Non-invasive Blood Pressure for Mice and Rats March 2011, 1-12. Animal Lab News, Kent Scientific Corporation, Torrington, Connecticut, USA.
20. Kubota Y., Umegaki K., Kagota S., Tanaka N., Nakamura K., Kunitomo M., Shinozuka K. Evaluation of blood pressure measured by tail-cuff methods (without heating) in spontaneously hypertensive rats. Biol. Pharm. Bull. 2006, 29:1756-1758.
21. Goes T.C., Antunes F.D., Almeida-Souza T.H., Ursulino F.R.C., Garcez F.B., Melo A.L.L., Teixeira-Silva F. Comportamento de ratos Wistar no Paradigma da Exploração Livre. Scientia Plena 2013, 9:1-7.
22. Leira E.C., Acharva A.B., Cruz-Flores S., Albaker O.J., Rao V.K., Abdulrauf S.I. Blood pressure surge precedes intracerebral hemorrhage. Neurocrit. Care 2005, 2:43-45.
23. Fonseca F.C.A., Coelho R.Z., Nicolato R., Malloy-Diniz L.F., Filho H.C.S. A influência de fatores emocionais sobre a hipertensão arterial. J. Bras. Psiquiatr. 2009, 58:128-134.
24. Rutledge T., Brenda E., Hogan M.A. A quantitative review of prospective evidence linking psychological factors with hypertension development. Psychosom. Med. 2002, 64:758-766.
25. Berntson G.G., Sarter M., Cacioppo J.T. Anxiety and cardiovascular reactivity: the basal forebrain cholinergic link. Behav. Brain Res. 1998, 94:225-248.
26. Andreatini R. A importância dos modelos animais em psiquiatria. Rev. Bras. Psiquiatr. 2002, 24:164.
27. Matthews K.A., Woodall K.L., Allen M.T. Cardiovascular reactivity to stress predicts future blood pressure status. Hypertension 1993, 22:479-485.
28. Watkins L.L., Grossman P., Krishnan R., Sherwood A. Anxiety and vagal control of heart rate. Psychosom. Med. 1998, 60:498-502.
29. James S.A. Psychosocial precursors of hypertension: a review of the epidemiologic evidence. Circulation 1987, 76:I60-I66.
30. Friedman B.H., Thayer J.F. Autonomic balance revisited: panic anxiety and heart rate variability. J. Psychosom. Res. 1998, 44:133-151.
31. Gaburro S., Stiedl O., Sartori P., Landgraf S.B., Singewald R. A mouse model of high trait anxiety shows reduced heart rate variability that can be reversed by anxiolytic drug treatment. Int. J. Clin. Exp. Neuropsychol. 2011, 14:1341-1355.
32. Sévoz-Couche C., Brouillard C., Camus F., Laude D., De Boer S.F., Becker C., Benoliel J.J. Involvement of the dorsomedial hypothalamus and the nucleus tractus solitarii in chronic cardiovascular changes associated with anxiety in rats. J. Physiol. 2013, 591:1871-1887.
33. Yeragani V.K., Pohl R., Srinivasan K., Balon R., Ramesh C., Berchou R. Effects of isoproterenol infusions on heart rate variability in patients with panic disorder. Psychiatry Res. 1995, 56:289-293.
34. Fuller B.F. The effects of stress-anxiety and coping styles on heart rate variability. Int. J. Psychophysiol. 1992, 12:81-86.
35. Ghiadoni L., Donald A.E., Cropley M., Mullen M.J., Oakley G., Taylor M., O'Connor G., Betteridge J., Klein N., Steptoe A., Deanfield J.E. Mental stress induces transient endothelial dysfunction in humans. Circulation 2000, 102:2473-2478.
36. Narita K., Murata T., Hamada T., Takahashi T., Kosaka H., Yoshida H., Wada Y. Association between trait anxiety and endothelial function observed in elderly males but not in young males. Int. Psychogeriatr. 2007, 19:947-954.
37. Napoli C., de Nigris F., Williams-Ignarro S., Pignalosa O., Sica V., Ignarro L.J. Nitric oxide and atherosclerosis: an update. Nitric Oxide 2006, 15:265-279.
38. Lerman L.O., Chade A.R., Sica V., Napoli C. Animal models of hypertension: an overview. J. Lab. Clin. Med. 2005, 146:160-173.
39. Boutelle R.C., Epstein S., Ruddy M.C. The relation of essential hypertension to feelings of anxiety, depression and anger. Psychiatry 1987, 50:206-217.
40. Grimsrud A., Stein D.J., Seedat S., Williams D., Myer L. The association between hypertension and depression and anxiety disorders: results from a nationally-representative sample of South African adults. PLoS ONE 2009, 4:1-9.
41. Vlachakis N.D., Schiavi R., Mendlowitz M., De Guia D., Wolf R.L. Hypertension and anxiety. Am. Heart J. 1974, 87:518-526.
42. Wei T.M., Wang L. Anxiety symptoms in patients with hypertension: a community-based study. Int. J. Psychiatry Med. 2006, 36:315-322.
43. Rosa W.C., Oliveira G.M., Nakamura-Palacios.E.M. Effects of the antihypertensive drugs alpha-methyldopa and hydralazine on the performance of spontaneously hypertensive rats in the elevated plus-maze. Braz. J. Med. Biol. Res. 1994, 27:55-59.